Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis

References

• Syngle A. Arthritis and its treatment. Prevention and treatment of age‐related diseases, S Rattan, M Kassem. Springer, The Netherlands 2006; 105–32
   Google Scholar
• Hürlimann D., Forster A., Noll G., Enseleit F., Chenevard R., Distler O., et al. Anti‐tumour necrosis factor‐alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002; 106: 2184–7
   PubMed Web of Science ®Google Scholar
• Gonzalez‐Gay M. A., Gonzalez‐Juanatey C., Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005; 35: 8–17
   PubMed Web of Science ®Google Scholar
• Gerli R., Goodson N. J. Cardiovascular involvement in rheumatoid arthritis. Lupus 2005; 14: 679–82
   PubMedGoogle Scholar
• del Rincón I., Escalante A. Atherosclerotic cardiovascular disease in rheumatoid arthritis. Curr Rheumatol Rep 2003; 5: 278–86
   PubMedGoogle Scholar
• Gonzalez‐Juanatey C., Testa A., Garcia‐Castelo A., Garcia‐Porrua C., Llorca J., Vidan J., et al. HLA‐DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 2003; 114: 647–52
   PubMed Web of Science ®Google Scholar
• Bilsborough W., Keen H., Taylor A., O'Driscoll G. J., Arnolda L., Green D. J. Anti‐tumour necrosis factor‐alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis. Rheumatol Int 2006; 26: 1125–31
   PubMedGoogle Scholar
• Vaudo G., Marchesi S., Gerli R., Allegrucci R., Giordano A., Siepi D., et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004; 63: 31–5
   PubMed Web of Science ®Google Scholar
• Dessein P. H., Joffe B. I., Singh S. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 2005; 7: R634–43
   PubMed Web of Science ®Google Scholar
• Schmitt‐Sody M., Metz P., Klose A., Gottschalk O., Zysk S., Hausdorf J., et al. In vivo interactions of platelets and leucocytes with the endothelium in murine antigen‐induced arthritis: the role of P‐selectin. Scand J Rheumatol 2007; 36: 311–19
   PubMed Web of Science ®Google Scholar
• Lipsky P. E., Van der Heijde D. M., St Clair E. W., Furst D. E., Breedveld F. C., Kalden J. R., et al. Infliximab and methotrexate in treatment of rheumatoid arthritis. Anti‐Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 2000; 343: 1594–602
   PubMed Web of Science ®Google Scholar
• Blake G. J., Ridker P. M. Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89: 763–71
   PubMed Web of Science ®Google Scholar
• Davignon J., Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: III27–32
   PubMed Web of Science ®Google Scholar
• Janmohamed S., Bouloux P. M. The pharmacological treatment of primary aldosteronism. Expert Opin Pharmacother 2006; 7: 563–73
   PubMed Web of Science ®Google Scholar
• Macdonald J. E., Kennedy N., Struthers A. D. Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment. Heart 2004; 90: 765–70
   PubMed Web of Science ®Google Scholar
• Bendtzen K., Hansen P. R., Rieneck K. Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor‐alpha and interferon‐gamma, and has potential in the treatment of arthritis. Clin Exp Immunol 2003; 134: 151–8
   PubMedGoogle Scholar
• Sastry K. V., Moudgal R. P., Mohan J., Tyagi J. S., Rao G. S. Spectrophotometric determination of serum nitrite and nitrate by copper‐cadmium alloy. Anal Biochem 2002; 306: 79–82
   PubMed Web of Science ®Google Scholar
• Himento M., Ishibashi T., Nakano S., Furuya K., Kigoshi T., Uchida K., et al. A practical procedure for achieving a steady state of NOx concentration in plasma: with special reference to NOx content of Japanese daily food. Tohoku J Exp Med 2003; 199: 95–110
   PubMedGoogle Scholar
• Aletaha D., Nell Valerie P. K., Stamm T., Uffmann M., Pflugbeil S., Machold K., et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005; 7: R796–806
   PubMed Web of Science ®Google Scholar
• Kumar A., Malaviya A. N., Pandhi A., Singh R. Validation of an Indian version of the Health Assessment Questionnaire in patients with rheumatoid arthritis. Rheumatology (Oxford) 2002; 41: 1457–9
   PubMedGoogle Scholar
• Wållberg‐Jonsson S., Caidahl K., Klintland N., Nyberg G., Rantapää‐Dahlqvist S. Increased arterial stiffness and indication of endothelial dysfunction in long‐standing rheumatoid arthritis. Scand J Rheumatol 2008; 37: 1–5
   PubMed Web of Science ®Google Scholar
• Bergholm R., Leirisalo‐Repo M., Vehkavaara S., Mäkimattila S., Taskinen M. R., Yki‐Järvinen H. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol 2002; 22: 1637–41
   PubMedGoogle Scholar
• Gonzalez‐Juanatey C., Testa A., Garcia‐Castelo A., Garcia‐Porrua C., Llorca J., Gonzalez‐Gay M. A. Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long‐term treatment with anti‐tumor necrosis factor α antibody. Arthritis Rheum 2004; 51: 447–50
   PubMed Web of Science ®Google Scholar
• Ruschitzka F., Michel B. A., Hellermann J. P., Gay R. E., Luscher T. F., Gay S., et al. Simvastatin improves endothelial function in patients with rheumatoid arthritis. J Am Coll Cardiol 2005; 45: 461–4
   PubMedGoogle Scholar
• Tikiz C., Utuk O., Pirildar T., Bayturan O., Bayindir P., Taneli F., et al. Effects of angiotensin‐converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with long‐term rheumatoid arthritis. J Rheumatol 2005; 32: 2095–101
   PubMed Web of Science ®Google Scholar
• Wong M., Jiang B. Y., McNeill K., Farish S., Kirkham B., Chowienczyk P. Effects of selective and non‐selective cyclo‐oxygenase inhibition on endothelial function in patients with rheumatoid arthritis. Scand J Rheumatol 2007; 36: 265–9
   PubMed Web of Science ®Google Scholar
• Hansen P. R., Rieneck K., Bendtzen K. Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells. Immunol Lett 2004; 91: 87–91
   PubMed Web of Science ®Google Scholar
• Yki‐Jarvinen H., Bergholm R., Leirisalo‐Repo M. Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis. Ann Rheum Dis 2003; 62: 630–4
   PubMed Web of Science ®Google Scholar
• Vita J. A., Keaney J. F. Jr., Larson M. G., Keyes M. J., Massaro J. M., Lipinska I., et al. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation 2004; 110: 3604–9
   PubMed Web of Science ®Google Scholar
• Sierksma A., van der Gaag M. S., Grobbee D. E., Hendriks H. F. Acute and chronic effects of dinner with alcoholic beverages on nitric oxide metabolites in healthy men. Clin Exp Pharmacol Physiol 2003; 30: 504–6
   PubMedGoogle Scholar
• Bots M. L., Westerink J., Rabelink T. J., de Koning E. J. Assessment of flow‐mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J 2005; 26: 363–8
   PubMed Web of Science ®Google Scholar
• Endemann D. H., Schiffrin E. L. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983–92
   PubMed Web of Science ®Google Scholar